Skip to main content

Table 1 Demographic and laboratory characteristics of the investigated groups

From: Evaluation of hepcidin level in chronic hepatitis C Egyptian patients undergoing regular hemodialysis

 

Control group

N = 20

HD patients

N = 80

P

HCV – ve HD

N = 40

HCV + ve HD

N = 40

P

Demographic data

Gender (male ♂/female♀]

11/9

49/31

NS

27/13

22/18

NS

Age “years”

31.55 ± 11.02

52.26 ± 12.28

< 0.001

51.42 ± 2.14

53.10 ± 1.73

NS

HD duration “years”

0

3.55 ± 3.608

< 0.001

2.20 ± 0.41

4.90 ± 0.63

P < 0.001

Clinical profile

Creatinine “mg/dl”

0.78 ± 0.14

5.37 ± 2.54

< 0.01

4.28 ± 0.39

6.46 ± 0.33

P < 0.001

Urea “mg/dl”

24.7 ± 7.81

176.18 ± 78.75

P < 0.001

144.70 ± 12.50

207.65 ± 10.33

P < 0.001

Sodium “mmol/l”

143.65 ± 4.82

152.64 ± 140.68

P < 0.001

169.97 ± 31.24

135.30 ± 3.26

NS

Potassium “mmol/l”

3.83 ± 0.35

6.52 ± 1.62

NS

6.00 ± 0.21

7.04 ± 0.26

P < 0.001

ALT “u/l”

16.7 ± 3.64

23.51 ± 7.62

P < 0.001

22.35 ± 1.10

24.67 ± 1.28

NS

AST “u/l”

17.45 ± 3.87

33.13 ± 10.55

P < 0.001

34.22 ± 1.56

32.02 ± 1.77

NS

Albumin “g/dl”

4.05 ± 0.29

3.89 ± 0.38

P < 0.001

4.03 ± 0.06

3.75 ± 0.04

NS

Total bilirubin “mg/dl”

0.65 ± 0.13

0.84 ± 0.25

NS

0.69 ± 0.02

0.98 ± 0.04

P < 0.01

  1. All data are presented as mean ± SD, N number of cases, HD haemodialysis, AST aspartate aminotransferase, ALT alanine aminotransferase, TLC total leucocyte count, RBCs red blood cells count, NS non-significant